ReviewCurrent hypertension reports2013
An update on the salt wars-genuine controversy, poor science, or vested interest?
Review in Current hypertension reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.
- The Science of Salt: A regularly updated systematic review of the implementation of salt reduction interventions (September 2016-February 2017).Journal of clinical hypertension (Greenwich, Conn.) · 2017Pooled it
- Reduced dietary salt for the prevention of cardiovascular disease.The Cochrane database of systematic reviews · 2014Pooled it
- Public health consequences of global climate change. A narrative review.Frontiers in cellular and infection microbiology · 2026Review
- Ultra-long-term human salt balance studies reveal interrelations between sodium, potassium, and chloride intake and excretion.The American journal of clinical nutrition · 2016Article
- Announcing "Up to Date in the Science of Sodium".Journal of clinical hypertension (Greenwich, Conn.) · 2016Article
- Controversial sodium guidelines: scientific solution or perpetual debate?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015Article
- Too much focus on low-quality science?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015Article
- Article
- The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.PloS one · 2015Article
- Measuring population sodium intake: a review of methods.Nutrients · 2014Review
- A call for quality research on salt intake and health: from the World Hypertension League and supporting organizations.Journal of clinical hypertension (Greenwich, Conn.) · 2014Article
- Cost-effectiveness of reducing salt intake in the Pacific Islands: protocol for a before and after intervention study.BMC public health · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is unequivocal evidence that increased sodium intake is associated with increased blood pressure, and that increased blood pressure leads to increased risk of vascular diseases. Unfortunately, the published evidence directly linking sodium intake to vascular risk is inconsistent and confusing. This review, emphasising recent developments in national and international settings, considers why this is the case and how vested interests - particularly the food industry - have exploited the vacuum. We argue that legislation is the only tool that is likely to reverse the current situation wherein many millions of lives are put at risk through an unnecessary dietary additive, the reduction of which would be eminently feasible and have no conceivable disadvantage to health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.